ArticleOne health (Amsterdam, Netherlands)2026
Climate-driven shifts in lumpy skin disease risk across Iran: Insights from ensemble species distribution models.
Article in One health (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to identify the environmental determinants influencing the distribution of lumpy skin disease and to predict changes in its spatial distribution risk and potential geographic range across Iran under future climate change scenarios using ensemble Species Distribution Models (SDMs). To this end, following data cleaning and quality control of 3654 disease occurrence records, a total of 2849 presence points recorded between 2013 and 2024 were retained for model development. The CTA, GAM, GBM, and RF algorithms were implemented within an ensemble modelling framework. The final ensemble model (EMca) achieved a True Skill Statistic (TSS) score of 0.85, an area under the receiver operating characteristic curve (AUC) of 0.96, and a Boyce index of 0.96 during calibration. For the validation data, the corresponding scores were 0.66, 0.89, and 0.93, respectively. The model therefore demonstrated broadly consistent predictive performance across calibration and validation based on these three evaluation metrics. Future projections were generated using three General Circulation Models (GCMs) HadGEM3-GC31-LL, MIROC6, and MPI-ESM1-2-HR under the SSP2-4.5 and SSP5-8.5 climate scenarios for the 2021-2040 and 2041-2060 time periods. The results indicated that hydrological, anthropogenic, and climatic variables were the three primary determinants of the spatial distribution of lumpy skin disease. Among the predictor variables, distance to rivers, distance to roads, and annual precipitation were identified as the most influential factors governing disease distribution, respectively. Furthermore, the risk maps revealed that western and northwestern Iran, together with the Zagros Mountain Range, which currently represent the principal disease hotspots, are projected to remain the major potential hotspots under future climate change scenarios. Range size analysis further indicated that although a proportion of the currently suitable areas for lumpy skin disease is projected to be lost under future climate conditions, the emergence of newly suitable areas is expected to largely offset these losses. Consequently, the net change in the disease's potential range is predicted to be minimal during the 2021-2040 period (-0.98%). However, this decline is projected to increase to -4.34% under the SSP2-4.5 scenario and -8.01% under the SSP5-8.5 scenario during the 2041-2060 period. Overall, the findings suggest that, in the near future, climate change is more likely to drive a spatial reorganization of disease risk hotspots than to cause a substantial expansion of the disease's potential distribution. These findings provide a robust scientific basis for targeted surveillance, strategic vaccination, and the development of early warning systems for the effective management of lumpy skin disease in Iran.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.